Sherwin-Williams Co: “The price-to-earnings multiple is still way too high on that stock. … I think the stock goes lower.”
Cassava Sciences Inc: “This is the kind of company that could strike gold or not, but you’ve got to understand you could lose everything.”
Boeing Co: “Right now, you’ve still got to avoid the stock.”
Seagen Inc: “I think Merck has to buy it. I would not sell this stock here, I’d be a buyer.”
Source: https://www.cnbc.com/2022/09/29/cramers-lightning-round-charles-river-is-a-buy.html